Drug Maker To Pay Over $17.5M To Settle Claims It Hid Issues With Cancer Drug
BOSTON — A biopharmaceutical company and certain of its executive officers will pay more than $17.5 million to settle claims that they misrepresented poor clinical trial results for the company’s cancer...To view the full article, register now.
Already a subscriber? Click here to view full article